Predicting post-stroke infections and outcome with blood-based immune and stress markers

Cerebrovascular Diseases

Volumn 33, Issue 6, 2012, Pages 580-588

  Meisel, Andreas ^a   Meisel, Christian ^b   Harms, Hendrik ^a   Hartmann, Oliver ^c   Ulm, Lena ^a  

^a Center for Stroke Research Berlin   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c THERMO FISHER SCIENTIFIC   (Germany)

Author keywords

Biomarkers; Copeptin; HLA DR; Immunodepression; Infection; MR proANP; Prognosis; Stroke; Withdrawal of life support

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; ATRIAL NATRIURETIC FACTOR; BIOLOGICAL MARKER; CEFTRIAXONE; CLARITHROMYCIN; COPEPTIN; LEVOFLOXACIN; MEZLOCILLIN; MOXIFLOXACIN; SULBACTAM;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; DIFFUSION WEIGHTED IMAGING; HUMAN; INFECTION; INFECTION PREVENTION; MORTALITY; NEUROIMAGING; NONHUMAN; PERFUSION WEIGHTED IMAGING; PREDICTION; PRIORITY JOURNAL; STRESS; STROKE;

ANIMALS; BIOLOGICAL MARKERS; CENTRAL NERVOUS SYSTEM; GLYCOPEPTIDES; HUMANS; INFECTION; STRESS, PHYSIOLOGICAL; STROKE;

EID: 84862260476     PISSN: 10159770     EISSN: 14219786     Source Type: Journal    
DOI: 10.1159/000338080     Document Type: Article

References (84)

1. Mathers CD, Boerma T, Ma Fat D: Global and regional causes of death. Br Med Bull 2009; 92: 7-32.
2. Meisel C, Schwab JM, Prass K, Meisel A, Dirnagl U: Central nervous system injury-induced immune deficiency syndrome. Nat Rev Neurosci 2005; 6: 775-786. (Pubitemid 41679240)
3. Koennecke HC, Belz W, Berfelde D, Endres M, Fitzek S, Hamilton F, Kreitsch P, Mackert BM, Nabavi DG, Nolte CH, Pohls W, Schmehl I, Schmitz B, von Brevern M, Walter G, Heuschmann PU: Factors influencing inhospital mortality and morbidity in patients treated on a stroke unit. Neurology 2011; 77: 965-972.
4. Hilker R, Poetter C, Findeisen N, Sobesky J, Jacobs A, Neveling M, Heiss WD: Nosocomial pneumonia after acute stroke: implications for neurological intensive care medicine. Stroke 2003; 34: 975-981. (Pubitemid 36402972)
5. Langhorne P, Stott DJ, Robertson L, Mac-Donald J, Jones L, McAlpine C, Dick F, Taylor GS, Murray G: Medical complications after stroke: a multicenter study. Stroke 2000; 31: 1223-1229. (Pubitemid 30351237)
6. Katzan IL, Cebul RD, Husak SH, Dawson NV, Baker DW: The effect of pneumonia on mortality among patients hospitalized for acute stroke. Neurology 2003; 60: 620-625. (Pubitemid 36246079)
7. Aslanyan S, Weir CJ, Diener HC, Kaste M, Lees KR: Pneumonia and urinary tract infection after acute ischaemic stroke: a tertiary analysis of the GAIN International trial. Eur J Neurol 2004; 11: 49-53. (Pubitemid 38174922)
8. Hong KS, Kang DW, Koo JS, Yu KH, Han MK, Cho YJ, Park JM, Bae HJ, Lee BC: Impact of neurological and medical complications on 3-month outcomes in acute ischaemic stroke. Eur J Neurol 2008; 15: 1324-1331.
9. Wartenberg KE, Stoll A, Funk A, Meyer A, Schmidt JM, Berrouschot J: Infection after acute ischemic stroke: risk factors, biomarkers, and outcome. Stroke Res Treat 2011; 2011: 830614.
10. Kumar S, Selim MH, Caplan LR: Medical complications after stroke. Lancet Neurol 2010; 9: 105-118.
11. Polderman KH: Induced hypothermia and fever control for prevention and treatment of neurological injuries. Lancet 2008; 371: 1955-1969. (Pubitemid 351780491)
12. van der Worp HB, Macleod MR, Kollmar R: Therapeutic hypothermia for acute ischemic stroke: ready to start large randomized trials? J Cereb Blood Flow Metab 2010; 30: 1079-1093.
13. Hemmen TM, Raman R, Guluma KZ, Meyer BC, Gomes JA, Cruz-Flores S, Wijman CA, Rapp KS, Grotta JC, Lyden PD: Intravenous thrombolysis plus hypothermia for acute treatment of ischemic stroke (ICTuS-L): final results. Stroke 2010; 41: 2265-2270.
14. Meisel A: Effective fever control in acute stroke: still wanted! Cerebrovasc Dis 2011; 31: 390-391.
15. Prass K, Meisel C, Hoflich C, Braun J, Halle E, Wolf T, Ruscher K, Victorov IV, Priller J, Dirnagl U, Volk HD, Meisel A: Stroke-induced immunodeficiency promotes spontaneous bacterial infections and is mediated by sympathetic activation reversal by poststroke T helper cell type 1-like immunostimulation. J Exp Med 2003; 198: 725-736. (Pubitemid 37087772)
16. Meisel C, Prass K, Braun J, Victorov I, Wolf T, Megow D, Halle E, Volk HD, Dirnagl U, Meisel A: Preventive antibacterial treatment improves the general medical and neurological outcome in a mouse model of stroke. Stroke 2004; 35: 2-6. (Pubitemid 38057579)
17. Westendorp WF, Vermeij JD, Vermeij F, Den Hertog HM, Dippel DW, van de Beek D, Nederkoorn PJ: Antibiotic therapy for preventing infections in patients with acute stroke. Cochrane Database Syst Rev 2012; 1:CD008530.
18. Feuerstein GZ, Chavez J: Translational medicine for stroke drug discovery: the pharmaceutical industry perspective. Stroke 2009; 40(3 Suppl):S121-125.
19. Bruno A, Biller J, Adams HP, Jr., Clarke WR, Woolson RF, Williams LS, Hansen MD: Acute blood glucose level and outcome from ischemic stroke. Trial of ORG 10172 in Acute Stroke Treatment (TOAST) Investigators. Neurology 1999; 52: 280-284. (Pubitemid 29059052)
20. Hajat C, Hajat S, Sharma P: Effects of poststroke pyrexia on stroke outcome: a metaanalysis of studies in patients. Stroke 2000; 31: 410-414. (Pubitemid 30078174)
21. Nuutinen J, Liu Y, Laakso MP, Karonen JO, Roivainen R, Vanninen RL, Partanen K, Ostergaard L, Sivenius J, Aronen HJ: Assessing the outcome of stroke: a comparison between MRI and clinical stroke scales. Acta Neurol Scand 2006; 113: 100-107.
22. Whiteley W, Chong WL, Sengupta A, Sandercock P: Blood markers for the prognosis of ischemic stroke: a systematic review. Stroke 2009; 40:e380-e389.
23. Ahmad O, Wardlaw J, Whiteley WN: Correlation of levels of neuronal and glial markers with radiological measures of infarct volume in ischaemic stroke: a systematic review. Cerebrovasc Dis 2012; 33: 47-54.
24. Hasan N, McColgan P, Bentley P, Edwards RJ, Sharma P: Towards the identification of blood biomarkers for acute stroke in humans: a comprehensive systematic review. Br J Clin Pharmacol 2012, E-pub ahead of print.
25. Nakajoh K, Nakagawa T, Sekizawa K, Matsui T, Arai H, Sasaki H: Relation between incidence of pneumonia and protective reflexes in post-stroke patients with oral or tube feeding. J Intern Med 2000; 247: 39-42. (Pubitemid 30073162)
26. Dirnagl U, Klehmet J, Braun JS, Harms H, Meisel C, Ziemssen T, Prass K, Meisel A: Stroke-induced immunodepression: experimental evidence and clinical relevance. Stroke 2007; 38(suppl 2):770-773. (Pubitemid 46184257)
27. Chamorro A, Urra X, Planas AM: Infection after acute ischemic stroke: a manifestation of brain-induced immunodepression. Stroke 2007; 38: 1097-1103. (Pubitemid 46568484)
28. Emsley HC, Hopkins SJ: Acute ischaemic stroke and infection: recent and emerging concepts. Lancet Neurol 2008; 7: 341-353. (Pubitemid 351380535)
29. Dziedzic T, Slowik A, Szczudlik A: Nosocomial infections and immunity: lesson from brain-injured patients. Crit Care 2004; 8: 266-270. (Pubitemid 39144717)
30. Wong CH, Jenne CN, Lee WY, Leger C, Kubes P: Functional innervation of hepatic iNKT cells is immunosuppressive following stroke. Science 2011; 334: 101-105.
31. Harms H, Prass K, Meisel C, Klehmet J, Rogge W, Drenckhahn C, Gohler J, Bereswill S, Gobel U, Wernecke KD, Wolf T, Arnold G, Halle E, Volk HD, Dirnagl U, Meisel A: Preventive antibacterial therapy in acute ischemic stroke: a randomized controlled trial. PLoS One 2008; 3:e2158.
32. Haeusler KG, Schmidt WU, Fohring F, Meisel C, Helms T, Jungehulsing GJ, Nolte CH, Schmolke K, Wegner B, Meisel A, Dirnagl U, Villringer A, Volk HD: Cellular immunodepression preceding infectious complications after acute ischemic stroke in humans. Cerebrovasc Dis 2008; 25: 50-58. (Pubitemid 351280375)
33. Chamorro A, Amaro S, Vargas M, Obach V, Cervera A, Torres F, Planas AM: Interleukin 10, monocytes and increased risk of early infection in ischaemic stroke. J Neurol Neurosurg Psychiatry 2006; 77: 1279-1281. (Pubitemid 44654763)
34. Czlonkowska A, Ryglewicz D, Lechowicz W: Basic analytical parameters as the predictive factors for 30-day case fatality rate in stroke. Acta Neurol Scand 1997; 95: 121-124. (Pubitemid 27107093)
35. Vogelgesang A, Grunwald U, Langner S, Jack R, Broker BM, Kessler C, Dressel A: Analysis of lymphocyte subsets in patients with stroke and their influence on infection after stroke. Stroke 2008; 39: 237-241.
36. Woiciechowsky C, Asadullah K, Nestler D, Eberhardt B, Platzer C, Schoning B, Glockner F, Lanksch WR, Volk HD, Docke WD: Sympathetic activation triggers systemic interleukin-10 release in immunodepression induced by brain injury. Nat Med 1998; 4: 808-813. (Pubitemid 28331022)
37. Chamorro A, Amaro S, Vargas M, Obach V, Cervera A, Gomez-Choco M, Torres F, Planas AM: Catecholamines, infection, and death in acute ischemic stroke. J Neurol Sci 2007; 252: 29-35. (Pubitemid 44909185)
38. Prass K, Braun JS, Dirnagl U, Meisel C, Meisel A: Stroke propagates bacterial aspiration to pneumonia in a model of cerebral ischemia. Stroke 2006; 37: 2607-2612. (Pubitemid 44454686)
39. Harms H, Reimnitz P, Bohner G, Werich T, Klingebiel R, Meisel C, Meisel A: Influence of stroke localization on autonomic activation, immunodepression, and post-stroke infection. Cerebrovasc Dis 2011; 32: 552-560.
40. Meisel C, Meisel A: Suppressing immunosuppression after stroke. N Engl J Med 2011; 365: 2134-2136.
41. Schabitz WR, Kruger C, Pitzer C, Weber D, Laage R, Gassler N, Aronowski J, Mier W, Kirsch F, Dittgen T, Bach A, Sommer C, Schneider A: A neuroprotective function for the hematopoietic protein granulocyte-macrophage colony stimulating factor (GM-CSF). J Cereb Blood Flow Metab 2008; 28: 29-43.
42. Schabitz WR, Laage R, Vogt G, Koch W, Kollmar R, Schwab S, Schneider D, Hamann GF, Rosenkranz M, Veltkamp R, Fiebach JB, Hacke W, Grotta JC, Fisher M, Schneider A: AXIS: a trial of intravenous granulocyte colony-stimulating factor in acute ischemic stroke. Stroke 2010; 41: 2545-2551.
43. Brott T, Adams HP, Jr, Olinger CP, Marler JR, Barsan WG, Biller J, Spilker J, Holleran R, Eberle R, Hertzberg V, et al: Measurements of acute cerebral infarction: a clinical examination scale. Stroke 1989; 20: 864-870. (Pubitemid 19188240)
44. Lyden P, Raman R, Liu L, Grotta J, Broderick J, Olson S, Shaw S, Spilker J, Meyer B, Emr M, Warren M, Marler J: NIHSS training and certification using a new digital video disk is reliable. Stroke 2005; 36: 2446-2449. (Pubitemid 41566975)
45. Goldstein LB, Bertels C, Davis JN: Interrater reliability of the NIH stroke scale. Arch Neurol 1989; 46: 660-662. (Pubitemid 19150945)
46. Kwakkel G, Veerbeek JM, van Wegen EE, Nijland R, Harmeling-van der Wel BC, Dippel DW: Predictive value of the NIHSS for ADL outcome after ischemic hemispheric stroke: does timing of early assessment matter? J Neurol Sci 2010; 294: 57-61.
47. Di Napoli M, Papa F, Bocola V: C-reactive protein in ischemic stroke: an independent prognostic factor. Stroke 2001; 32: 917-924. (Pubitemid 32285161)
48. Welsh P, Barber M, Langhorne P, Rumley A, Lowe GD, Stott DJ: Associations of inflammatory and haemostatic biomarkers with poor outcome in acute ischaemic stroke. Cerebrovasc Dis 2009; 27: 247-253.
49. Elkind MS, Tai W, Coates K, Paik MC, Sacco RL: High-sensitivity C-reactive protein, lipoprotein-associated phospholipase A 2, and outcome after ischemic stroke. Arch Intern Med 2006; 166: 2073-2080. (Pubitemid 44631394)
50. Song IU, Kim JS, Kim YI, Lee KS, Jeong DS, Chung SW: Relationship between high-sensitivity C-reactive protein and clinical functional outcome after acute ischemic stroke in a Korean population. Cerebrovasc Dis 2009; 28: 545-550.
51. Worthmann H, Tryc AB, Goldbecker A, Ma YT, Tountopoulou A, Hahn A, Dengler R, Lichtinghagen R, Weissenborn K: The temporal profile of inflammatory markers and mediators in blood after acute ischemic stroke differs depending on stroke outcome. Cerebrovasc Dis 2010; 30: 85-92.
52. Smith CJ, Emsley HC, Gavin CM, Georgiou RF, Vail A, Barberan EM, del Zoppo GJ, Hallenbeck JM, Rothwell NJ, Hopkins SJ, Tyrrell PJ: Peak plasma interleukin-6 and other peripheral markers of inflammation in the first week of ischaemic stroke correlate with brain infarct volume, stroke severity and longterm outcome. BMC Neurol 2004; 4: 2.
53. Urra X, Villamor N, Amaro S, Gomez-Choco M, Obach V, Oleaga L, Planas AM, Chamorro A: Monocyte subtypes predict clinical course and prognosis in human stroke. J Cereb Blood Flow Metab 2009; 29: 994-1002.
54. Urra X, Cervera A, Obach V, Climent N, Planas AM, Chamorro A: Monocytes are major players in the prognosis and risk of infection after acute stroke. Stroke 2009; 40: 1262-1268.
55. Cervera A, Planas AM, Justicia C, Urra X, Jensenius JC, Torres F, Lozano F, Chamorro A: Genetically-defined deficiency of mannose-binding lectin is associated with protection after experimental stroke in mice and outcome in human stroke. PLoS One 2010; 5:e8433.
56. Worthmann H, Kempf T, Widera C, Tryc AB, Goldbecker A, Ma YT, Deb M, Tountopoulou A, Lambrecht J, Heeren M, Lichtinghagen R, Wollert KC, Weissenborn K: Growth differentiation factor 15 plasma levels and outcome after ischemic stroke. Cerebrovasc Dis 2011; 32: 72-78.
57. Katan M, Fluri F, Morgenthaler NG, Schuetz P, Zweifel C, Bingisser R, Muller K, Meckel S, Gass A, Kappos L, Steck AJ, Engelter ST, Muller B, Christ-Crain M: Copeptin: a novel, independent prognostic marker in patients with ischemic stroke. Ann Neurol 2009; 66: 799-808.
58. Urwyler SA, Schuetz P, Fluri F, Morgenthaler NG, Zweifel C, Bergmann A, Bingisser R, Kappos L, Steck A, Engelter S, Muller B, Christ-Crain M, Katan M: Prognostic value of copeptin: one-year outcome in patients with acute stroke. Stroke 2010; 41: 1564-1567.
59. Katan M, Fluri F, Schuetz P, Morgenthaler NG, Zweifel C, Bingisser R, Kappos L, Steck A, Engelter ST, Muller B, Christ-Crain M: Midregional pro-atrial natriuretic peptide and outcome in patients with acute ischemic stroke. J Am Coll Cardiol 2010; 56: 1045-1053.
60. Whiteley W, Jackson C, Lewis S, Lowe G, Rumley A, Sandercock P, Wardlaw J, Dennis M, Sudlow C: Inflammatory markers and poor outcome after stroke: a prospective cohort study and systematic review of interleukin-6. PLoS Med 2009; 6:e1000145.
61. Whiteley W, Wardlaw J, Dennis M, Lowe G, Rumley A, Sattar N, Welsh P, Green A, Andrews M, Sandercock P: The use of blood biomarkers to predict poor outcome after acute transient ischemic attack or ischemic stroke. Stroke 2012; 43: 86-91.
62. Giacomini M, Cook D, DeJean D, Shaw R, Gedge E: Decision tools for life support: a review and policy analysis. Crit Care Med 2006; 34: 864-870.
63. Gedge E, Giacomini M, Cook D: Withholding and withdrawing life support in critical care settings: ethical issues concerning consent. J Med Ethics 2007; 33: 215-218.
64. Ferrand E, Robert R, Ingrand P, Lemaire F: Withholding and withdrawal of life support in intensive-care units in France: a prospective survey. French LATAREA Group. Lancet 2001; 357: 9-14. (Pubitemid 32056494)
65. Prendergast TJ, Claessens MT, Luce JM: A national survey of end-of-life care for critically ill patients. Am J Respir Crit Care Med. 1998; 158: 1163-1167. (Pubitemid 28489017)
66. Wunsch H, Harrison DA, Harvey S, Rowan K: End-of-life decisions: a cohort study of the withdrawal of all active treatment in intensive care units in the United Kingdom. Intensive Care Med 2005; 31: 823-831. (Pubitemid 40897538)
67. Varelas PN, Abdelhak T, Hacein-Bey L: Withdrawal of life-sustaining therapies and brain death in the intensive care unit. Semin Neurol 2008; 28: 726-735.
68. Sprung CL, Cohen SL, Sjokvist P, Baras M, Bulow HH, Hovilehto S, Ledoux D, Lippert A, Maia P, Phelan D, Schobersberger W, Wennberg E, Woodcock T: End-of-life practices in European intensive care units: the Ethicus Study. JAMA 2003; 290: 790-797. (Pubitemid 37432956)
69. Cook D, Rocker G, Marshall J, Sjokvist P, Dodek P, Griffith L, Freitag A, Varon J, Bradley C, Levy M, Finfer S, Hamielec C, McMullin J, Weaver B, Walter S, Guyatt G: Withdrawal of mechanical ventilation in anticipation of death in the intensive care unit. N Engl J Med 2003; 349: 1123-1132. (Pubitemid 37122324)
70. Smedira NG, Evans BH, Grais LS, Cohen NH, Lo B, Cooke M, Schecter WP, Fink C, Epstein-Jaffe E, May C, et al: Withholding and withdrawal of life support from the critically ill. N Engl J Med 1990; 322: 309-315. (Pubitemid 20046334)
71. Wood GG, Martin E: Withholding and withdrawing life-sustaining therapy in a Canadian intensive care unit. Can J Anaesth 1995; 42: 186-191.
72. Prendergast TJ, Puntillo KA: Withdrawal of life support: intensive caring at the end of life. JAMA 2002; 288: 2732-2740. (Pubitemid 35403787)
73. Sinuff T, Adhikari NK, Cook DJ, Schunemann HJ, Griffith LE, Rocker G, Walter SD: Mortality predictions in the intensive care unit: comparing physicians with scoring systems. Crit Care Med 2006; 34: 878-885.
74. Worthmann H, Tryc AB, Deb M, Goldbecker A, Ma YT, Tountopoulou A, Lichtinghagen R, Weissenborn K: Linking infection and inflammation in acute ischemic stroke. Ann NY Acad Sci 2010; 1207: 116-122.
75. Zandbergen EG, Hijdra A, Koelman JH, Hart AA, Vos PE, Verbeek MM, de Haan RJ: Prediction of poor outcome within the first 3 days of postanoxic coma. Neurology 2006; 66: 62-68. (Pubitemid 43739593)
76. Wijdicks EF, Hijdra A, Young GB, Bassetti CL, Wiebe S: Practice parameter: prediction of outcome in comatose survivors after cardiopulmonary resuscitation (an evidencebased review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2006; 67: 203-210. (Pubitemid 44305400)
77. Steffen IG, Hasper D, Ploner CJ, Schefold JC, Dietz E, Martens F, Nee J, Krueger A, Jorres A, Storm C: Mild therapeutic hypothermia alters neuron specific enolase as an outcome predictor after resuscitation: 97 prospective hypothermia patients compared to 133 historical non-hypothermia patients. Crit Care 2010; 14:R69.
78. Fugate JE, Wijdicks EF, Mandrekar J, Claassen DO, Manno EM, White RD, Bell MR, Rabinstein AA: Predictors of neurologic outcome in hypothermia after cardiac arrest. Ann Neurol 2010; 68: 907-914.
79. Chamorro A, Horcajada JP, Obach V, Vargas M, Revilla M, Torres F, Cervera A, Planas AM, Mensa J: The Early Systemic Prophylaxis of Infection After Stroke study: a randomized clinical trial. Stroke 2005; 36: 1495-1500. (Pubitemid 40967519)
80. Schwarz S, Al-Shajlawi F, Sick C, Meairs S, Hennerici MG: Effects of prophylactic antibiotic therapy with mezlocillin plus sulbactam on the incidence and height of fever after severe acute ischemic stroke: the Mannheim infection in stroke study (MISS). Stroke 2008; 39: 1220-1227. (Pubitemid 351440694)
81. Nederkoorn PJ, Westendorp WF, Hooijenga IJ, de Haan RJ, Dippel DW, Vermeij FH, Dijkgraaf MG, Prins JM, Spanjaard L, van de Beek D: Preventive antibiotics in stroke study: rationale and protocol for a randomised trial. Int J Stroke 2011; 6: 159-163.
82. Liesz A, Hagmann S, Zschoche C, Adamek J, Zhou W, Sun L, Hug A, Zorn M, Dalpke A, Nawroth P, Veltkamp R: The spectrum of systemic immune alterations after murine focal ischemia: immunodepression versus immunomodulation. Stroke 2009; 40: 2849-2858.
83. Klehmet J, Harms H, Richter M, Prass K, Volk HD, Dirnagl U, Meisel A, Meisel C: Stroke-induced immunodepression and post-stroke infections: lessons from the preventive antibacterial therapy in stroke trial. Neuroscience 2009; 158: 1184-1193.
84. Zhang DP, Yan FL, Xu HQ, Zhu YX, Yin Y, Lu HQ: A decrease of human leucocyte antigen-DR expression on monocytes in peripheral blood predicts stroke-associated infection in critically-ill patients with acute stroke. Eur J Neurol 2009; 16: 498-505.